Zydus Lifesciences Limited has informed the Exchange regarding a press release dated April 17, 2025, titled "Zydus Medtech and Braile Biomedica of Brazil announce global licensing pact to commercialise TAVI technology".
Press Release Apr 17 2025
Filed with NSE · · 4 pages · English
Summary by 6ix AI
This partnership allows Zydus MedTech to market the innovative Transcatheter Aortic Valve Implantation technology in various regions including India and Europe. The press release emphasizes the commitment of both companies to improve patient outcomes through advanced medical technologies.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Apr 16 2025
- Press Release Apr 11 2025
- Press Release Mar 18 2025
- Press Release Mar 16 2025
- Press Release Mar 14 2025
Later from Zydus Lifesciences
- ITC Reversal Of Common ITC U/s17(2) Required In Relation To Activity Of Subscription And Redemption Of Mutual Funds
- Press Release Apr 25 2025
- Press Release Apr 26 2025
- Press Release Apr 30 2025
- Zydus Receives Final Approval From USFDA for Glatiramer Acetate Injection, the Generic Version of Copaxone® 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences